Unique ID issued by UMIN | UMIN000040198 |
---|---|
Receipt number | R000045838 |
Scientific Title | Effects of Artificial Intelligence (AI)-Supported Automated Nutritional Intervention on LDL cholesterol Control in Patients with familial hypercholesterolemia (iSTART-FH) |
Date of disclosure of the study information | 2020/09/01 |
Last modified on | 2022/04/21 14:30:35 |
Effects of Artificial Intelligence (AI)-Supported Automated Nutritional Intervention on LDL cholesterol Control in Patients with familial hypercholesterolemia (iSTART-FH)
Effects of Artificial Intelligence (AI)-Supported Automated Nutritional Intervention on LDL cholesterol Control in Patients with familial hypercholesterolemia (iSTART-FH)
Effects of Artificial Intelligence (AI)-Supported Automated Nutritional Intervention on LDL cholesterol Control in Patients with familial hypercholesterolemia (iSTART-FH)
Effects of Artificial Intelligence (AI)-Supported Automated Nutritional Intervention on LDL cholesterol Control in Patients with familial hypercholesterolemia (iSTART-FH)
Japan |
Familial Hypercholesterolemia
Cardiology |
Others
NO
Investigated the efficacy of Artificial Intelligence (AI)-Supported Automated Nutritional Intervention on LDL cholesterol Control in Patients with familial hypercholesterolemia
Efficacy
Absolute change of LDL-C from baseline (at 12 months)
Fasting glucose
Cost
Blood pressure
Serum lipids (TCHO, TG, HDL-C)
Urin albmin
New onset of diabetes
Changes in lipid-lowering therapies
Frequency of use of application
Absolute LDL-C change due to the change of nutritional intake
Interventional
Cross-over
Randomized
Individual
Open -no one is blinded
Active
2
Treatment
Device,equipment |
Nutritional intervention through amartphnoe application(for 12 month)
Standard nutritional counseling
20 | years-old | <= |
Not applicable |
Male and Female
who is applicable to all of those
Pateints with FH regarldess of medical therapies, gender, and ASCVD
Disgnostic criteria is used by Japan Atherosclerosis Society 2017
LDL-C 100 mg/dL or over
age 20 years or over
who can used smartphone app
who provide written informed consent to this study
who is applicable to one of those
diabetes, malignant hypertension, secondary hypertension
under insulin therapy
Female with pregnancy or expected
eGFR< 45ml/min/1.73m2
severe Liver dysfunction
within 1 year from myocardial infarction or stroke
allergy and/or nuder steroid
pancreatitis (active or history)
under treatment of malignancies
Patients whose doctors in charge consider him/her inappropriate to participate
60
1st name | Hayato |
Middle name | |
Last name | Tada |
Kanazawa University Hospital
Department of Cardiology
920-8641
13-1 Takara-machi, Kanazawa
0762652000
ht240z@sa3.so-net.ne.jp
1st name | Hayato |
Middle name | |
Last name | Tada |
Kanazawa University Hospital
Department of Cardiology
920-8641
13-1 Takara-machi, Kanazawa
0762652000
ht240z@sa3.so-net.ne.jp
Kanazawa University Hospital
Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences
Self funding
JAPAN
IRB of the Kanazawa University
13-1 Takara-machi, Kanazawa
0762652832
rinri@adm.kanazawa-u.ac.jp
NO
金沢大学附属病院(石川県)
2020 | Year | 09 | Month | 01 | Day |
Unpublished
Enrolling by invitation
2020 | Year | 07 | Month | 01 | Day |
2020 | Year | 06 | Month | 17 | Day |
2020 | Year | 09 | Month | 01 | Day |
2024 | Year | 12 | Month | 31 | Day |
2020 | Year | 04 | Month | 19 | Day |
2022 | Year | 04 | Month | 21 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045838